Authors
Loading...
Randomized trial evaluates statin eligibility based on individualized benefit in cardiovascular disease prevention, suggesting improved treatment guidelines.
Thanassoulis et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: